Clincosm LogoSign in Get a demo

prostate cancer

Showing NaN - NaN of 185
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Glioblastoma, Melanoma Stage IV, Melanoma Recurrent Trial in United Kingdom, United States (ST101)

Recruiting
  • Glioblastoma
  • +11 more
  • San Francisco, California
  • +11 more
Jul 13, 2022

Ovarian Cancer, Breast Cancer, Pancreatic Cancer Trial in Worldwide (AZD5305, Paclitaxel, Carboplatin)

Recruiting
  • Ovarian Cancer
  • +12 more
  • San Francisco, California
  • +44 more
Jul 12, 2022

Prostate Cancer Trial in Canada, United States (Casodex, Eulexin, LHRH agonist)

Completed
Has Results
  • Prostate Cancer
  • Birmingham, Alabama
  • +260 more
May 23, 2022

Prostate Cancer Trial in Canada, United States (bicalutamide, radiation therapy, )

Completed
Has Results
  • Prostate Cancer
  • Birmingham, Alabama
  • +239 more
May 23, 2022

Cushing's Disease, Acromegaly, Neuroendocrine Tumors Trial in Worldwide (Pasireotide, Cabergoline)

Active, not recruiting
  • Cushing's Disease
  • +8 more
  • La Jolla, California
  • +93 more
May 19, 2022

Prostate Cancer Trial in Worldwide (Multiparametric MRI +/- prostate biopsy, Biparametric MRI +/- prostate biopsy)

Recruiting
  • Prostate Cancer
  • Multiparametric MRI +/- prostate biopsy
  • Biparametric MRI +/- prostate biopsy
  • Rochester, Minnesota
  • +30 more
May 11, 2022

Prostate Cancer Trial in Canada (Adavosertib, Savolitinib, Darolutamide)

Recruiting
  • Prostate Cancer
  • Edmonton, Alberta, Canada
  • +10 more
May 9, 2022

Prostate Cancer Trial in London (Clinical decision support tool recommended outcome)

Not yet recruiting
  • Prostate Cancer
  • Clinical decision support tool recommended outcome
  • London, United Kingdom
  • +1 more
Apr 27, 2022

Prostate Cancer, Non Small Cell Lung Cancer, Ovarian Cancer Trial in London, Oxford (OVM-200)

Recruiting
  • Prostate Cancer
  • +2 more
  • OVM-200
  • London, United Kingdom
  • +2 more
Apr 26, 2022

Mental Wellbeing and Quality of Life in Prostate Cancer

Recruiting
  • Prostate Cancer
    • Bedford, Bedfordshire, United Kingdom
    • +6 more
    Apr 14, 2022

    Prostate Cancer Trial in Canada (Abiraterone acetate with prednisone, Leuprolide, Cabazitaxel with peg-filgrastim)

    Completed
    • Prostate Cancer
    • Abiraterone acetate with prednisone
    • +2 more
    • Vancouver, British Columbia, Canada
    • +4 more
    Apr 13, 2022

    Prostate Cancer Trial in Calgary, Kelowna, London (Conventionally-fractionated WPRT, Hypofractionated WPRT)

    Active, not recruiting
    • Prostate Cancer
    • Conventionally-fractionated WPRT
    • Hypofractionated WPRT
    • Calgary, Alberta, Canada
    • +2 more
    Apr 12, 2022

    ReIMAGINE Prostate Cancer Risk

    Active, not recruiting
    • Prostate Cancer
    • Tissue donation
    • +3 more
    • London, United Kingdom
    • +2 more
    Apr 8, 2022

    Prostate Cancer Trial in Australia, Canada, United Kingdom (18F-FCH PET/MRI Scan)

    Completed
    • Prostate Cancer
    • 18F-FCH PET/MRI Scan
    • Sydney, New South Wales, Australia
    • +9 more
    Apr 4, 2022

    An Imaging Study of FCH-PET-CT in Prostate Cancer andBRCA Gene

    Recruiting
    • Prostate Cancer
    • +2 more
    • MRI pelvis or CT imaging
    • +2 more
    • London, Sutton, Surrey, United Kingdom
      Cancer Genetics Unit, Royal Marsden Hospital
    Mar 30, 2022

    Prostate Cancer Trial in Hamilton, London, Toronto (18F-DCFPyL PET/CT scan)

    Completed
    • Prostate Cancer
    • 18F-DCFPyL PET/CT scan
    • Hamilton, Ontario, Canada
    • +3 more
    Mar 24, 2022

    Prostate Cancer Trial in Canada (Durvalumab, Tremelimumab)

    Active, not recruiting
    • Prostate Cancer
    • Kelowna, British Columbia, Canada
    • +10 more
    Mar 14, 2022

    EMT on CTCs and Disease Progression in Prostate Cancer

    Active, not recruiting
    • Prostate Cancer
    • CellSearch CTC platform
    • Parsortix CTC platform
    • London, Ontario, Canada
      London Regional Cancer Program
    Mar 5, 2022

    Nonmetastatic Castration-Resistant Prostate Cancer, Prostate Cancer, Cancer of the Prostate Trial in Worldwide (Enzalutamide,

    Active, not recruiting
    Has Results
    • Nonmetastatic Castration-Resistant Prostate Cancer
    • +2 more
    • Tucson, Arizona
    • +396 more
    Feb 22, 2022

    Prostate Cancer Trial in Canada (Palbociclib)

    Active, not recruiting
    • Prostate Cancer
    • Halifax, Nova Scotia, Canada
    • +6 more
    Jan 28, 2022

    Prostate Cancer Trial in Worldwide (Relugolix, Leuprolide Acetate)

    Completed
    Has Results
    • Prostate Cancer
    • Tucson, Arizona
    • +161 more
    Jan 6, 2022

    Prostate Cancer Trial in Hamilton, London, Toronto (Molecular Imaging)

    Completed
    • Prostate Cancer
    • Molecular Imaging
    • Hamilton, Ontario, Canada
    • +2 more
    Dec 20, 2021

    Prostate Cancer, Prostate Adenocarcinoma, Prostate Tumor Trial in London (PET Scan, [F-18]-DCFPyL Injection, Sodium MRI)

    Recruiting
    • Prostate Cancer
    • +2 more
    • PET Scan
    • +3 more
    • London, Ontario, Canada
      London Health Sciences Centre
    Dec 6, 2021

    Prostate Cancer Trial in London (Imaging Panel)

    Active, not recruiting
    • Prostate Cancer
    • Imaging Panel
    • London, Ontario, Canada
      London Health Sciences Centre
    Dec 14, 2021

    Prostate Cancer Trial in Worldwide (Active surveillance)

    Recruiting
    • Prostate Cancer
    • Active surveillance
    • Odense, Denmark
    • +19 more
    Nov 18, 2021